Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

View source ↗

Summary

The study evaluating golimumab in Filipino patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: WITHDRAWN